SmNACE inhibitors (Trudeau)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSmNACE inhibitors (Trudeau)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLymphocyte differentiation antigen CD38 inhibitors
TargetsLymphocyte differentiation antigen CD38
Therapy Area/IndicationsSchistosomiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrudeau Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrudeau Institute
Active IndicationsN/A
Inactive IndicationsSchistosomiasis

Other Information

ATC CodeN/A
Related LinksN/A